Literature DB >> 25445404

The diagnosis of inflammatory bowel disease is often unsupported in clinical practice.

Gabriella Canavese1, Vincenzo Villanacci2, Anna Sapino3, Rodolfo Rocca4, Marco Daperno4, Renzo Suriani4, Francesca Maletta3, Paola Cassoni3.   

Abstract

BACKGROUND: The diagnosis of inflammatory bowel disease can be challenging and requires the efforts of a multidisciplinary team. We performed a retrospective analysis with the aim of evaluating the adequacy of the prerequisites for arriving at an accurate histological diagnosis.
METHODS: The following parameters were considered as prerequisites for a diagnosis of inflammatory bowel disease: clinical and endoscopic data; proper sampling and handling of biopsies; and elementary microscopic lesions. We collected 345 cases from 13 centres.
RESULTS: The date of onset and treatment were available for 13% and 16% of the cases, respectively. Endoscopy information was accessible for 77% of the cases. Endoscopic mapping was completed in 13% of the cases. In no cases were the biopsies oriented on acetate strips. The diagnosis was conclusive in 47% of the cases. Activity, epithelial disruption and crypt distortion were described in 35% of the reports with a conclusive diagnosis.
CONCLUSION: Our study showed that the diagnostic prerequisites were widely unfulfilled, although approximately half of the diagnoses were conclusive for inflammatory bowel disease. Thus, in our assessment of clinical practice: (1) clinicians seldom provide suitable clinical and/or endoscopic information for a histological diagnosis and (2) histopathological diagnoses of inflammatory bowel disease are often not supported by morphology.
Copyright © 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis; Inflammatory bowel disease

Mesh:

Year:  2014        PMID: 25445404     DOI: 10.1016/j.dld.2014.09.007

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  5 in total

Review 1.  Role of MiRNAs in Inflammatory Bowel Disease.

Authors:  Bo Cao; Xin Zhou; Jiaojiao Ma; Wei Zhou; Wanli Yang; Daiming Fan; Liu Hong
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

Review 2.  Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD).

Authors:  Vincenzo Villanacci; Luca Reggiani-Bonetti; Tiziana Salviato; Giuseppe Leoncini; Moris Cadei; Luca Albarello; Alessandro Caputo; Maria Costanza Aquilano; Serena Battista; Paola Parente
Journal:  Pathologica       Date:  2021-02

3.  Usefulness of Different Pathological Scores to Assess Healing of the Mucosa in Inflammatory Bowel Diseases: A Real Life Study.

Authors:  Vincenzo Villanacci; Elisabetta Antonelli; Francesco Lanzarotto; Anna Bozzola; Moris Cadei; Gabrio Bassotti
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

Review 4.  Roles of microRNAs in inflammatory bowel disease.

Authors:  HyunTaek Jung; Jae Seok Kim; Keum Hwa Lee; Kalthoum Tizaoui; Salvatore Terrazzino; Sarah Cargnin; Lee Smith; Ai Koyanagi; Louis Jacob; Han Li; Sung Hwi Hong; Dong Keon Yon; Seung Won Lee; Min Seo Kim; Paul Wasuwanich; Wikrom Karnsakul; Jae Il Shin; Andreas Kronbichler
Journal:  Int J Biol Sci       Date:  2021-05-17       Impact factor: 6.580

Review 5.  Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?

Authors:  Lihui Lin; Gaoshi Zhou; Peng Chen; Ying Wang; Jing Han; Minhu Chen; Yao He; Shenghong Zhang
Journal:  Cell Death Dis       Date:  2020-06-15       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.